Abstract
Innovation and improvement in surgical technology have resulted in advances such as robot-assisted surgery. For a subset of patients with head and neck malignancies, particularly oropharyngeal carcinoma, transoral robotic surgery (TORS) offers a minimally invasive treatment option. The use of TORS has the potential to reduce morbidity and improve patients' quality of life. As more head and neck cancer patients are offered the option of robotic-assisted surgeries, patients will inevitably look to their GPs for advice and to seek answers.
Original language | English |
---|---|
Pages (from-to) | 54-58 |
Number of pages | 5 |
Journal | Medicine Today |
Volume | 21 |
Issue number | 10 |
Publication status | Published - Oct 2020 |